Md. Mahbub Hasan
Role not yet determined Is this you? Add your title
Also affiliated: Khulna University of Engineering and Technology (2025); George Mason University (2023); Dhaka University of Engineering & Technology (2021–2026); Bangladesh University of Professionals (2017)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Md. Mahbub Hasan's research investigates the molecular mechanisms underlying gene regulation, with a particular focus on the role of splicing factors and epigenetic modifiers in cancer development. His work explores the regulatory networks that control gene expression, specifically investigating how proteins like SRSF6 and SRSF1 influence RNA splicing to generate specific protein isoforms. Hasan has also studied the oncogenic functions of Enhancer of Zeste Homolog 2 (EZH2) and explored potential therapeutic strategies, such as antisense oligonucleotide-based correction, to target these aberrant splicing events in neoplastic conditions. His publications span various disciplines, including nanotechnology for drug delivery, machine learning applications for cybersecurity, and photonic crystal fiber applications for sensing, indicating a broad research interest. Hasan has an h-index of 4 based on 8 publications, with a total of 136 citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Preeti Nagar, Mohammad Alinoor Rahman, Md. Rafikul Islam, and Shabiha Afroj Heeamoni.
Metrics
- h-index: 4
- Publications: 8
- Citations: 138
Selected Publications
-
Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction (2026)
-
CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer (2026)
-
Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction (2026)
-
SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform (2025)
Collaboration Network
Top Collaborators
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
Similar Researchers
Based on overlapping research topics